🇺🇸 FDA
Patent

US 7608693

High affinity human antibodies to human IL-4 receptor

granted A61KA61K2039/505A61K39/3955

Quick answer

US patent 7608693 (High affinity human antibodies to human IL-4 receptor) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2039/505, A61K39/3955, A61K45/06, A61P